3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
107
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
Recurrence
20
Leukemia
18
Burkitt Lymphoma
18
Lymphoma
17
Neoplasms, Plasma Cell
13
Lymphoma, Non-Hodgkin
13
Nausea
12
Lymphoma, Mantle-Cell
12
Vomiting
11
Waldenstrom Macroglobulinemia
10
Breast Neoplasms
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Neoplasms
9
Lymphoma, Follicular
9
Immunoglobulin Light-chain Amyloidosis
8
Lymphoma, B-Cell, Marginal Zone
7
Hodgkin Disease
7
Amyloidosis
7
Smoldering Multiple Myeloma
6
Lymphoma, Large B-Cell, Diffuse
6
Leukemia, Myeloid, Acute
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Prostatic Neoplasms
5
Leukemia, Biphenotypic, Acute
5
Hematologic Neoplasms
5
Sezary Syndrome
4
Mycosis Fungoides
4
Lymphoma, T-Cell, Cutaneous
4
Interventions
tislelizumab
4
talazoparib
4
pembrolizumab
4
Docetaxel
4
Nivolumab
3
PM 01183
2
MLN 8237
2
Itraconazole
2
Fluorouracil
2
Cisplatin
2
Carboplatin
2
zimberelimab
1
utomilumab
1
urelumab
1
ulixertinib
1
trifluridine tipiracil drug combination
1
sitravatinib
1
sapanisertib
1
pexidartinib
1
pevonedistat
1
peposertib
1
niraparib
1
mogamulizumab
1
lenvatinib
1
ixabepilone
1
eribulin
1
durvalumab
1
dalotuzumab
1
avelumab
1
ascrinvacumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Solid Tumors
×
Calcium Dobesilate
×
Clear all
No trials found.